Terms: = Skin cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2
15 results:
1. A phase Ib/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinoma.
Zhou M; Zhu S; Xu C; Liu B; Shen J
Invest New Drugs; 2023 Feb; 41(1):162-167. PubMed ID: 36763233
[TBL] [Abstract] [Full Text] [Related]
2. Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis.
Pathmanathan S; Babu H; Dzienis M; Azer M; Eastgate M
Pigment Cell Melanoma Res; 2022 Nov; 35(6):587-594. PubMed ID: 36065524
[TBL] [Abstract] [Full Text] [Related]
3.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract] [Full Text] [Related]
4. Trametinib Induces the Stabilization of a Dual
Krebs FS; Gérard C; Wicky A; Aedo-Lopez V; Missiaglia E; Bisig B; Trimech M; Michielin O; Homicsko K; Zoete V
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126538
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of Benign and Malignant Pilomatricomas Using Whole-exome Sequencing.
Yeo MK; Bae GE
Cancer Genomics Proteomics; 2020; 17(6):795-802. PubMed ID: 33099480
[TBL] [Abstract] [Full Text] [Related]
6. [Protection of nerve function during transoral endoscopic thyroidectomy by vestibular approach].
Wu Z; Fang JG; Chen X; Hou LZ; Zhong Q; Ma HZ; Zhang Y; Shen XX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):893-898. PubMed ID: 33036502
[No Abstract] [Full Text] [Related]
7. Germline variant fgfr4 p.G388R exposes a membrane-proximal STAT3 binding site.
Ulaganathan VK; Sperl B; Rapp UR; Ullrich A
Nature; 2015 Dec; 528(7583):570-4. PubMed ID: 26675719
[TBL] [Abstract] [Full Text] [Related]
8. Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment.
Smalley KS; Flaherty KT
Future Oncol; 2009 Aug; 5(6):775-8. PubMed ID: 19663727
[TBL] [Abstract] [Full Text] [Related]
9. Genetic variants in FGFR2 and fgfr4 genes and skin cancer risk in the Nurses' Health Study.
Nan H; Qureshi AA; Hunter DJ; Han J
BMC Cancer; 2009 Jun; 9():172. PubMed ID: 19500394
[TBL] [Abstract] [Full Text] [Related]
10. Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.
Meijer D; Sieuwerts AM; Look MP; van Agthoven T; Foekens JA; Dorssers LC
Endocr Relat Cancer; 2008 Mar; 15(1):101-11. PubMed ID: 18310279
[TBL] [Abstract] [Full Text] [Related]
11. fgfr4 Arg388 allele correlates with tumour thickness and fgfr4 protein expression with survival of melanoma patients.
Streit S; Mestel DS; Schmidt M; Ullrich A; Berking C
Br J Cancer; 2006 Jun; 94(12):1879-86. PubMed ID: 16721364
[TBL] [Abstract] [Full Text] [Related]
12. Protein tyrosine kinases in malignant melanoma.
Easty DJ; Bennett DC
Melanoma Res; 2000 Oct; 10(5):401-11. PubMed ID: 11095400
[TBL] [Abstract] [Full Text] [Related]
13. FGF-19, a novel fibroblast growth factor with unique specificity for fgfr4.
Xie MH; Holcomb I; Deuel B; Dowd P; Huang A; Vagts A; Foster J; Liang J; Brush J; Gu Q; Hillan K; Goddard A; Gurney AL
Cytokine; 1999 Oct; 11(10):729-35. PubMed ID: 10525310
[TBL] [Abstract] [Full Text] [Related]
14. Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer.
Regazzoni S; Pesce G; Marini G; Cavalli F; Goldhirsch A
Ann Oncol; 1996 Oct; 7(8):807-13. PubMed ID: 8922194
[TBL] [Abstract] [Full Text] [Related]
15. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.
Easty DJ; Herlyn M; Bennett DC
Int J Cancer; 1995 Jan; 60(1):129-36. PubMed ID: 7814145
[TBL] [Abstract] [Full Text] [Related]
